![Exteriors of the UNC Lineberger and Marsico Hall buildings](https://unclineberger.org/wp-content/uploads/sites/867/2021/12/Lineberger-Marsico-exterior-600x400.jpg)
November 18, 2022
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
November 18, 2022
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
July 22, 2022
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
March 24, 2022
Yevgeny Brudno, PhD, and colleagues from NC State University and UNC-Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T for attacking cancerous tumors.
January 31, 2022
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
September 25, 2020
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
September 16, 2020
Qi Zhang, PhD, Robert McGinty, MD, PhD, and team determined the high-resolution structure of a key DNA-sensing protein in the innate immune system called cGAS while it is bound to the nucleosome.
March 10, 2020
The University Committee on Teaching Awards has selected UNC Lineberger's Adrienne Cox, PhD, as a recipient of the Mentor Award for Lifetime Achievement.
February 11, 2020
Andrew Z. Wang, MD, was corresponding author of a paper evaluating whether nanoparticle drug delivery contributed to liver damage, or hepatotoxicity.
January 10, 2020
UNC Lineberger’s Channing Der, PhD, Sarah Graham Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, was co-corresponding author of a paper published in Cancer Discovery. Antje Schaefer, PhD, research assistant professor in the UNC School of Medicine Department of Pharmacology, was co-first author. In the study, researchers identified a new potential …
December 2, 2019
The North Carolina Biotechnology Center awarded $100,000 to UNC Lineberger Comprehensive Cancer Center’s Chad Pecot, MD, to study an experimental treatment that would silence a gene commonly mutated in cancer. Using a Nobel Prize-winning technology called RNA interference or RNAi, Pecot’s lab designed an investigational drug to shut down the mutated version of the KRAS …